SRC Family Kinase Inhibition Through a New Pyrazolo[3,4-d]Pyrimidine Derivative as a Feasible Approach for Glioblastoma Treatment
出版年份 2015 全文链接
标题
SRC Family Kinase Inhibition Through a New Pyrazolo[3,4-d]Pyrimidine Derivative as a Feasible Approach for Glioblastoma Treatment
作者
关键词
-
出版物
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 116, Issue 5, Pages 856-863
出版商
Wiley
发表日期
2014-12-17
DOI
10.1002/jcb.25042
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CYP-dependent Metabolism of Antitumor Pyrazolo[3,4-d]pyrimidine Derivatives Is Characterized by an Oxidative Dechlorination Reaction
- (2014) Claudio Zamperini et al. Drug Metabolism and Pharmacokinetics
- Glioblastoma and Other Malignant Gliomas
- (2013) Antonio Omuro JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Design, Synthesis, and Biological Evaluation of Pyrazolo[3,4-d]pyrimidines Active in Vivo on the Bcr-Abl T315I Mutant
- (2013) Marco Radi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Which drug or drug delivery system can change clinical practice for brain tumor therapy?
- (2013) T. Siegal NEURO-ONCOLOGY
- Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors
- (2013) Giulia Vignaroli et al. ACS Medicinal Chemistry Letters
- Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition
- (2012) Martina Cozzi et al. CELL CYCLE
- Synthesis, Biological Activity, and ADME Properties of Novel S-DABOs/N-DABOs as HIV Reverse Transcriptase Inhibitors
- (2012) Marco Radi et al. ChemMedChem
- Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells
- (2011) Marco Radi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, Synthesis, Biological Activity, and ADME Properties of Pyrazolo[3,4-d]pyrimidines Active in Hypoxic Human Leukemia Cells: A Lead Optimization Study
- (2011) Marco Radi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pathway inhibition: emerging molecular targets for treating glioblastoma
- (2011) W. Wick et al. NEURO-ONCOLOGY
- New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization
- (2011) P Indovina et al. ONCOGENE
- Novel dual Src/Abl inhibitors for hematologic and solid malignancies
- (2010) Silvia Schenone et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration
- (2010) Vipin Yadav et al. MOLECULAR CARCINOGENESIS
- Human De-epidermized Dermis as a Stem Cell Carrier
- (2010) E. Pianigiani et al. TRANSPLANTATION PROCEEDINGS
- Fyn and Src Are Effectors of Oncogenic Epidermal Growth Factor Receptor Signaling in Glioblastoma Patients
- (2009) K. V. Lu et al. CANCER RESEARCH
- Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma
- (2009) V. Milano et al. MOLECULAR CANCER THERAPEUTICS
- Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells
- (2008) Adriano Spreafico et al. FASEB JOURNAL
- Src Directly Phosphorylates Bif-1 and Prevents Its Interaction with Bax and the Initiation of Anoikis
- (2008) Hirohito Yamaguchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-Apoptosis Mechanisms in Malignant Gliomas
- (2008) David S. Ziegler et al. JOURNAL OF CLINICAL ONCOLOGY
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
- (2008) Jinyan Du et al. NATURE BIOTECHNOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now